Literature DB >> 26299677

Heart rate and adverse outcomes in patients with atrial fibrillation: A combined AFFIRM and AF-CHF substudy.

Jason G Andrade1, Denis Roy1, D George Wyse2, Jean-Claude Tardif3, Mario Talajic1, Hugues Leduc4, Julia-Cadrin Tourigny1, Azadeh Shohoudi4, Marc Dubuc1, Léna Rivard1, Peter G Guerra1, Bernard Thibault1, Katia Dyrda1, Laurent Macle1, Paul Khairy5.   

Abstract

BACKGROUND: An elevated resting heart rate has been associated with adverse cardiovascular outcomes. Its prognostic value has not specifically been examined in patients with atrial fibrillation.
OBJECTIVE: The purpose of this study was to assess the relationship between resting heart rate measured in sinus rhythm and in atrial fibrillation and subsequent hospitalizations and death.
METHODS: An analysis of individual patient-level data from subjects enrolled in the AFFIRM and AF-CHF trials was conducted to determine the impact of resting heart rate on hospitalizations and mortality. Separate analyses were performed in atrial fibrillation and sinus rhythm. A total of 7159 baseline ECGs (4848 in atrial fibrillation, 2311 in sinus rhythm) were analyzed in 5164 patients (34.8% female, age 68.2 ± 8.3 years).
RESULTS: During mean follow-up of 40.8 ± 16.3 months, 1016 patients died (668 cardiovascular deaths), and 3150 required at least 1 hospitalization (2215 cardiovascular). An elevated baseline heart rate in sinus rhythm was associated with increased all-cause mortality [hazard ratio (HR) 1.24 per 10 bpm increase, 95% confidence interval (CI) 1.14-1.36, P < .0001]. In contrast, a baseline heart rate in atrial fibrillation was not associated with mortality. However, compared to heart rates 90-114 bpm in atrial fibrillation, a heart rate >114 bpm was independently associated with all-cause (HR 1.18, 95% CI 1.06-1.31, P = .0018) and cardiovascular (HR 1.25, 95% CI 1.10-1.42, P = .0005) hospitalizations.
CONCLUSION: In patients with a history of atrial fibrillation, an elevated baseline heart rate in sinus rhythm is independently associated with mortality. In contrast, the baseline heart rate in atrial fibrillation is not associated with mortality but predicts hospitalizations.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Heart rate; Hospitalization; Mortality; Sinus rhythm

Mesh:

Year:  2015        PMID: 26299677     DOI: 10.1016/j.hrthm.2015.08.028

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

Review 1.  Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Virginia Mplani; Maria Anastasopoulou; Nicholas Kounis; Cesare de Gregorio; Grigorios Tsigkas; Arun Karunakaran; Panagiotis Plotas; Ignatios Ikonomidis
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

Review 2.  Management of Atrial Tachyarrhythmias in Heart Failure-an Interventionalist's Point of View.

Authors:  Jason A Gencher; Nathaniel M Hawkins; Marc W Deyell; Jason G Andrade
Journal:  Curr Heart Fail Rep       Date:  2022-03-30

Review 3.  Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society.

Authors:  Samuel Lévy; Gerhard Steinbeck; Luca Santini; Michael Nabauer; Diego Penela Maceda; Bharat K Kantharia; Sanjeev Saksena; Riccardo Cappato
Journal:  J Interv Card Electrophysiol       Date:  2022-04-13       Impact factor: 1.759

4.  Acute rate control in atrial fibrillation: an urgent need for the clinician.

Authors:  Gheorghe-Andrei Dan; Anca R Dan; Andreea Ivanescu; Adrian C Buzea
Journal:  Eur Heart J Suppl       Date:  2022-06-13       Impact factor: 1.624

5.  Heart rate determines the beneficial effects of beta-blockers on cardiovascular outcomes in patients with heart failure and atrial fibrillation.

Authors:  Athanasius Wrin Hudoyo; Hiroki Fukuda; Miki Imazu; Kazuhiro Shindo; Haiying Fu; Yuko Iwata; Shin Ito; Masafumi Kitakaze
Journal:  Hypertens Res       Date:  2019-06-18       Impact factor: 3.872

6.  Five-Year Outcomes and Cardiac Remodeling Following Left Atrial Appendage Occlusion.

Authors:  Baoxin Liu; Jiachen Luo; Mengmeng Gong; Zhiqiang Li; Beibei Shi; Xingxu Zhang; Xinqiang Han; Yidong Wei
Journal:  Clin Interv Aging       Date:  2021-04-19       Impact factor: 4.458

7.  Both beat-to-beat changes in RR-interval and left ventricular filling time determine ventricular function during atrial fibrillation.

Authors:  Aurore Lyon; Manouk van Mourik; Laura Cruts; Jordi Heijman; Sebastiaan C A M Bekkers; Ulrich Schotten; Harry J G M Crijns; Dominik Linz; Joost Lumens
Journal:  Europace       Date:  2021-03-04       Impact factor: 5.214

8.  California Study of Ablation for Atrial Fibrillation:Re-hospitalization for Cardiac Events (CAABL-CE).

Authors:  Uma N Srivatsa; Guibo Xing; Ezra Amsterdam; Nipavan Chiamvimonvat; Nayereh Pezeshkian; Dali Fan; Richard H White
Journal:  J Atr Fibrillation       Date:  2018-06-30

9.  Heart rate - A complex prognostic marker in acute heart failure.

Authors:  Jan Olligs; Dominik Linz; Dirk G Dechering; Lars Eckardt; Patrick Müller
Journal:  Int J Cardiol Heart Vasc       Date:  2019-12-28

10.  Cardiac autonomic function and cognitive performance in patients with atrial fibrillation.

Authors:  Michael Kühne; Christine S Zuern; Peter Hämmerle; Stefanie Aeschbacher; Anne Springer; Ceylan Eken; Michael Coslovsky; Gilles Dutilh; Giorgio Moschovitis; Nicolas Rodondi; Patricia Chocano; David Conen; Stefan Osswald
Journal:  Clin Res Cardiol       Date:  2021-06-22       Impact factor: 5.460

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.